Exscientia 17 déc. 2025 Recursion Pharmaceuticals Stock (RXRX) Opinions on Exscientia Merger and Clinical Data Readout - Quiver Quantitative
Exscientia 30 oct. 2025 BMS removes 2 clinical programs from pipeline, one from Mirati and another from Exscientia - Fierce Biotech
Exscientia 26 oct. 2025 Recursion Pharmaceuticals Stock (RXRX) Opinions on Exscientia Acquisition and Partnerships | RXRX Stock News - Quiver Quantitative
Exscientia 20 oct. 2025 Recursion Pharmaceuticals (RXRX) Is Up 6.0% After New AI Partnerships and Exscientia Acquisition Has the Bull Case Changed? - Yahoo Finance
Exscientia 13 oct. 2025 Exscientia Wins Dismissal of Investor Suit Over CEO Misconduct - Bloomberg Law News
Exscientia 28 mai 2025 The first test of Recursion's Exscientia move | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
Exscientia 2 oct. 2024 Exscientia outline robot and AI use in drug discovery workflow - Clinical Trials Arena